A few inborn errors Bruce R. Wall, MD, FACP October 10, 2005.

Slides:



Advertisements
Similar presentations
John Kanu UVA School of Medicine
Advertisements

Hereditary GI Cancer Syndromes: Keys to identify high risk patients
A mild form of Alport syndrome: Hereditary nephropathy in the absence of extra-renal features Yoon H-S, Wilson JC & Eccles MR Pathology, University of.
Renal Diseases Renal cysts and Tumors.
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
UNC Neuroradiology-Neuropathology Conference
Molecular pathogenesis of subarachnoid haemorrhage Baiping Zhang, Kaare Gugleholm, Lorna B. Day, Shu Ye, Roy O. Weller, Ian N.M. Day 5 November 2002.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
Renal Tumours n Mr C Dawson MS FRCS n Consultant Urologist n Fitzwilliam Hospital n Peterborough.
What is Li-Fraumeni syndrome?
Living Donor Kidney Transplantation in Hereditary Nephropathy Patients
Renal Cell Carcinoma & Other Solid renal lesions Dr Charles Chabert POW May 2005.
Cancer Genetics Diane Stirling McMillan Nurse Specialist in Genetics
Pancreatic cancer By Linda Sircy.
Women and Alport Syndrome Michelle Rheault, M.D. Assistant Professor Division of Pediatric Nephrology University of Minnesota, USA.
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
Management of T1 Kidney Cancer Laparoscopic Surgery
Case Report # [] Submitted by:Kandra Vogt, MSIV Faculty reviewer:Sandra A. A. Oldham, M.D. Date accepted:31 August 2007 Radiological Category:Principal.
Renal tumors Dr. Abdelaty Shawky Dr. Gehan Mohamed.
Ayman Abdo MD, AmBIM, FRCPC
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
BRAIN TUMOR. What is it?  Brain neoplasms are a diverse group of primary (nonmetastatic) tumors arising from one of the many different cell types within.
Emad Raddaoui, MD, FCAP, FASC Associate Professor; Consultant Histopathology & Cytopathology.
Hemangioblastoma.
Adjuvant therapy for renal cell carcinoma Dr.Mina Tajvidi oncologist.
Von Recklinghausen Neurofibromatosis NF1 By: Jessica Mollman.
Neurofibromatosis By Katelynn Johnson and Katie Duvall.
List at least 3 genetic conditions you know of. Why do you think they are genetic conditions?
Primary Spinal Tumors (Soft tissue tumors) H. Louis Harkey Department of Neurosurgery University of Mississippi Jackson, MS.
Thyroid nodules and neoplasms EMAD RADDAOUI, MD, FCAP, FASC ASSOCIATE PROFESSOR; CONSULTANT HISTOPATHOLOGY & CYTOPATHOLOGY.
Tinnitus in 44 y/o female Richard Lukose. Presents to family doctor A 44 y/o female Tinnitus in right ear for 1 month, worsening PMHx: obesity Medications:
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Adrenal Masses: Differential Dx and Work-up Sara Faber August 4, 2008.
Adult Polycystic Kidney Disease.  Autosomal dominant  1-2 per 1000  Cysts present at birth, progressively enlarge to compress renal parenchyma  Occurs.
DR. ERNEST K. ADJEI FRCPath. DEPARTMENT OF PATHOLOGY SMS-KATH
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
34 YO WHITE FEMALE WITH ABDOMINAL PAIN
10/2/2015 AQEEL ALGHAMDI 1. PROTEINURIA DR AQEEL ALGHAMDI MBBS,DCH,JBCP,ABP,FBN consultant pediatric nephrology 10/2/20152.
Chapter 7 Genetic and Developmental Diseases. Review of Structure and Function Fertilization is the uniting of a sperm and ovum resulting in 23 pairs.
Sex Linked Inheritance
Innocenzo RAINERO, MD PhD Neurology II – Department of Neuroscience, University of Torino ITALY VON HIPPEL-LINDAU DISEASE AND THE NERVOUS SYSTEM Corso.
HEMATURIA Danger Signal that can’t be ignored. 1. Duration of symptoms and are they painful? 2.Presence of symptoms of an irritated bladder 3.What portion.
The Function of VHL and pVHL Protein VHL is a tumor suppressor gene on chromosome 3 Helps to regulate and destroy the alpha subunit of hypoxia-inducible.
CYSTIC DISEASE OF KIDNEY Dr S Chakradhar 1. Classification of renal cyst Adult polycystic disease (Autosomal dominant disease) Adult polycystic disease.
Bruce R. Wall, MD, FACP February 2nd,  “I never questioned the integrity of an umpire… their eyesight, yes…” Leo Durocher  “About the only problem.
History 60 yr. old Female with a history of visual changes, balance problems, nausea, and abdominal pain.60 yr. old Female with a history of visual changes,
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
1 Tumors of Urinary Tract. 2 Urinary Tract Neoplasm KidneyRenal Cell Carcinoma [ adult], Transitional cell carcinoma [ adult], Wilms Tumor [children]
Inherited Syndrome. History 55 year old female presents with headaches, slurred speech and changes in short-term memory Pt also complained of gait abnormalities.
Assistant professor of pathology
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
بسم الله الرحمن الرحيم. POLYCYSTIC KIDNEY DISEASE Lecture by: Dr. Zaidan Jayed Zaidan.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Human Genetic Disorders Every cell in the human body has 46 chromosomes except for gametes, egg sperm cells, which contain 23 or the haploid number. Human.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
Renal tumors-1 Dr. Abdelaty Shawky Assistant professor of pathology 1.
Malignant Renal tumors DR.Gehan Mohamed. Malignant renal tumors - It may be: - primary tumors : i.e arise from kidney tissue itself - Secondary tumors:
Tuberous Sclerosis Abdullah M. Al-Olayan MBBS, SBP, ABP
Dr.Saad Dakhil. Overview About Kidney Cancer According to the American Cancer Society, an estimated 58,240 people in the United States will be diagnosed.
Presentation by JoAnn Czech RN/CDS St. Cloud Hospital.
Retinoblastoma Retinoblastoma is a rare form of eye cancer that develops in the retina usually before the age 5.
Dr.Amit Gupta Associate Professor Dept. of Surgery
Gene Expression and Retinoblastoma “Cancer of the Eye”
Assistant professor of pathology
Intramedullary spinal cord tumors
BY: VIVEK PATEL And FERNANDO CRUZ
Hemangioblastoma Intern 蔡佽學.
By Dr. Abeer Elsayed Aly Lecturer of medical oncology SECI 18/3/2013
Clinical Genetics Lecture 4.
Genetic Changes & Biotechnology
Presentation transcript:

A few inborn errors Bruce R. Wall, MD, FACP October 10, 2005

Contents:  Von Hippel-Landau disease  Alport’s syndrome (hereditary nephritis)  Fabry’s disease  Sturge Weber disease  Tuberous sclerosis  AD-PCKD  Too much…  Brief mystery case

Baseball season: famous quotes  “It ain’t about the heat, it’s the humility”  “He hits from both sides of the plate. He’s amphibious.”  “Baseball is 90% mental. The other half is physical.” Yogi Berra Yogi Berra

More baseball quotes  “I never questioned the integrity of an umpire… their eyesight, yes…” Leo Durocher  “About the only problem with success is that is does not teach you how to deal with failure” Tommy Lasorda  “I think the good Lord is a Yankee” Mariano Rivera  “You can only milk a cow so long, then you’re left holding the pail” Hank Aaron, retirement party 1976

Recent admission  60 yo WM with known von Hippel Landau  Previous native nephrectomy for RCC  Progressive CKD related to diabetes  Previous CNS screen (CT scan) negative for hemangioblastoma  No sign of episodic hypertension/pheo  No recent imaging of remaining kidney  Does he need bilateral nephrectomy??

History  1894: Von Hippel, German opthalmologist, recognized familial nature of retinal hemangioblastoma  1896: Arvid Landau, Swedish opthalmologist, added cerebellar and retinal hemorrhages – “angiomatosis of the central nervous system”  (noted renal and pancreatic involvement)  1964: landmark paper from Melmon and Rose codified term VHL disease

Clinical features of VHL  Inherited autosomal dominant syndrome with a variety of benign and malignant tumors  1 in 36,000 newborns  Hemangioblastomas, including retinal angiomas  Clear cell renal cell carcinomas (RCCs)  Pheochromocytoma  Endolymphatic sac tumor of the middle ear  Serous cystadenomas/neuroendocrine tumor of pancreas  Papillary cystadenomas of epididymis/broad ligament  Median actuarial survival was 49yrs; death from RCCs  Type I do not develop pheochromocytoma  Type II do have pheochromocytoma, +/- RCCs

Molecular pathogenesis of VHL  “Two hit model” with germline mutation that inactivates one copy of VHL gene in all cells  Gene whose normal function is regulate cell growth  Disease occurs with loss of expression of the second (normal allele) from either somatic mutation or hypermethylation of its promoter  VHL gene has been mapped to chromosome 3p25 and cloned  Gene product, pVHL, functions as tumor suppressor protein

Improving survival in VHL  Improved understanding of natural history of VHL-associated tumors  Surveillance strategies have led to detection of small asymptomatic tumors, prior to metastatic disease  Renal-sparing surgery in RCC decreases ESRD

Hemangioblastoma  Most common lesion; 60-85% of VHL pts; mean 29yrs of age  Conversely - among pts with HemangioB - 25% have VHL and 75% cases are sporadic  Well-circumscribed, capillary rich benign neoplasm cause pressure via hemorrhage  Opthalmoscopy + fluorescein angiograpy (not CT)  In VHL pts, HemangioB tend to be infratentorial and multiple (160pts: total of 655 tumors, including spinal cord, cerebellum and brain stem)  Management: can be dormant, unpredictable, +/- phases of accelerated growth  Stereotactic radiosurgery plus conventional radiation play a role in lesions not accessible to surgery

Retinal angiomas  Hemangioblastomas that develop in the retina or optic nerve  Affect 60% of VHL patients, often multifocal, and bilateral  Untreated causes hemorrhage, detachment, and loss of vision  VHL pts are younger (age 18), average 4 tumors  Laser photocoagulation and cryotherapy are effective > 70% (except optic nerve)  XRT may have a role for salvage; VEGF receptor inhibitors are being studied

Renal cell carcinoma  60% VHL pts develop multiple cysts & RCC  All VHL RCC are clear cell tumors (not papillary, chromophobe, or oncocytic histology)  Mean age of onset 44 years; 70% of patients surviving to age 60  Multicentric, bilateral, not restricted to cysts  Therapeutic approach to VHL-associated RCC has shifted from radical nephrectomy to renal sparing surgery

Renal sparing approach  Improved imaging modalities: CT, MRI, US  Solid renal tumors < 3cm have low metastatic potential, and can be monitored  Partial nephrectomy as effective as total nephrectomy for early RCC  Laparoscopic cryoablation or radioablation in patients with mulitple or bilateral tumors  85% develop new renal tumors by 10yrs (LC)  Transplantation in VHL post bilat nephrectomy is ok; no increased ‘tumorogenesis’ despite meds

Pheochromocytoma  Pheo can be sporadic in VHL, MEN 2, neurofibromatosis 1, succinate DeHYase Def  For VHL type II is subdivided based upon risk of RCC: Type IIA and IIB : low and high% of RCC  Type IIC have pheochromocytoma without RCC  Pheochromocytoma in VHL occur in younger pts, mulitple, extraadrenal, less sxs, difficult to Dx  NIH study: 64pts = 106 tumors; 12% extraadrenal  Mayo : 109pts = 20 tumors; 15% extraadrenal 33% failed evidence of catecholamine production

Endolymphatic sac tumors of the middle ear  Papillary cystadenomas are highly vascular lesion within middle ear  Occur at younger age; often bilateral  Common symptoms: hearing loss, tinnitus, vertigo, and facial muscle weakness  Generally slow growth rate; primary therapy is surgical  Radiosurgery may have a role

Pancreatic tumors  Common in pts with VHL  Multicenter study of 158 pts: 77% pancreatic lesions – cysts, adenomas, neuroendocrine tumors  Mostly asymptomatic, rarely pancreatitis  Neuroendocrine tumors can metastasize and produce secreted peptides (VIP,insulin)  Surgery is primary form of therapy

Papillary cystadenomas of epididymis or broad ligament  Single epididymal cyst is common in general population (does not mean pt has VHL)  Bilateral epididymal cysts are almost pathognomonic of VHL  No treatment is required  In women, symptoms may include pain and menorrhagia

Diagnosis: autosomal dominant disease  Clinical Dx based on finding TWO VHL-associated tumors  Genetic testing (DNA sequencing and quantitative Southern blot of VHL gene): 100% sensitive and specific  Germline mutations in VHL gene can be inherited or present de novo (20% of VHL kindreds)  Somatic mosaics: mutation occurs during embryonic development after fertilization; pt may present with classic VHL, yet mutation may not be detectable in peripheral blood (risk of transmission to children < 50%)  Counseling: VHL family Alliance (

Surveillance protocols:  Infants and children < age 11: annual retinal exam and plasma catecholamines  Adolescents > age 11: Plasma catecholamines and abd CT with contrast plus retinal exam plus MRI brain and spine with gadolinium  Adults: catecholamines, abd CT, retinal exam, MRI of CNS, MRI of kidneys, baseline ENT exam with audiometry

Genetics of PCKD: “nice gene”  Occurring in 1 in every 400 to 1000 births  < 50% will be diagnosed (clinically silent)  Most families abnormal chromosome 16 (called PKD1 locus)  Other gene is on chromosome 4 (PKD2 locus)  PKD1 96% of North America; 85% of Europe  Both encode proteins AKA “polycystin I & II”  PKD1 gene is adjacent to gene of Tuberous sclerosis (TSC2), associated with cyst formation (angiomyolipoma)  Genotype/phenotype correlation with PKD1 & 2 “unclear”

Polycystin 1  Localized in renal tubular epithelia, hepatic ductules, pancreatic ducts (all sites in PCKD)  Integral membrane protein  Less abundant in adult than fetal epithelia  Overexpressed in most cysts in kidney from PCKD patients  Cause abnormalities in renal cilia  Induce cell cycle arrest  Why is there variable phenotypic expression?  Defect is present in 100% of cells, yet only 10% of tubules form cysts… (second hit hypothesis?)  Therefore – mechanism of cyst formation and growth is unclear (abnormal differentiation or cell maturation)

Diagnosis and screening for PCKD  Easy diagnosis in overt disease: flank pain, positive family history, CRI, large kidneys with multiple bilateral cysts on CT or sono  Cysts in liver, pancreas, and spleen  What do you do with otherwise unexplained CRI, hematuria, with negative family hx?  Acquired cystic disease of the kidney

Mystery case  18 yo WF noted to have minimal proteinuria and microscopic 3 rd trimester  Abnormal urinalysis persisted post delivery  24 hour urine protein 800mg per day; GFR estimation of 90ml/hr  During 2 nd pregnancy at age 25 yrs: abn UA with 1200mg proteinuria with creatinine clearance of 82ml/hr  Negative serology for hepatitis B, lues, SLE, myeloma, Wegener’s, and VHL…  Diagnostic test was performed

Thin basement membrane diseaese  Benign familial hematuria – relatively common (autosomal dominant inheritance)  GBM decreased to nM vs 400nM  Along with IGA – common cause of asymptomatic hematuria  Heterozygous defect in COL4A3 or A4 (alpha-4 chains of type IV collagen)  Discovered via work up of microscopic hematuria (normal urine protein, BP, GFR)  Rare episodes of gross hematuria and flank pain from hypercalciuria or hyperuricosuria rather than GBM changes  Since GFR is usually normal, renal biopsy not done

Thin basement membrane disease  Hematuria represents and exaggeration of the normal process of naturally occurring leaks in the GBM  No extra renal manifestations: hearing loss, ocular abnormalities  Early renal biopsy difficult to distinguish from hereditary nephritis  Screen first degree relatives (autos dominant inheritance) – look for father to son inheritance, which is not seen in X linked nephritis (alport’s)  Rarely may lead to progressive CKD (?FSGN)